N Herrmann

Summary

Country: Canada

Publications

  1. ncbi The management of behavioural disturbances in dementia: the role of serotonergic therapies
    N Herrmann
    Division of Geriatric Psychiatry, Sunnybrook Health Science Center, Department of Pharmacology, University of Toronto, 2075 Bayview Avenue, Room FG20, North York, Ontario M4N 3M5, Canada
    IDrugs 1:214-20. 1998
  2. ncbi Effectiveness of gabapentin for the treatment of behavioral disorders in dementia
    N Herrmann
    Division of Geriatric Psychiatry, University of Toronto, Ontario, Canada
    J Clin Psychopharmacol 20:90-3. 2000
  3. doi Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes
    W Swardfager
    University of Toronto, Toronto, ON, Canada
    Diabet Med 33:529-36. 2016
  4. ncbi From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia
    N Herrmann
    University of Toronto, Ontario
    Can J Psychiatry 42:51S-64S. 1997
  5. pmc Poststroke neuropsychiatric symptoms: relationships with IL-17 and oxidative stress
    W Swardfager
    Neuropsychopharmacology Research Group, Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5 Department of Psychiatry, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5 Canadian Partnership for Stroke Recovery, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5 Division of Cognitive Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada M4N 3M5 L C Campbell Cognitive Neurology Research Unit, Sunnybrook Research Institute, Toronto, ON, Canada M4N 3M5
    Biomed Res Int 2014:245210. 2014
  6. ncbi Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
    A Adibfar
    Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Suite FG 08, M4N 3M5, Toronto, Canada
    Curr Mol Med 16:137-64. 2016
  7. ncbi Risperidone for the treatment of behavioral disturbances in dementia: a case series
    N Herrmann
    Sunnybrook Health Science Centre, University of Toronto, Royal Ottawa Hospital, University of Ottawa, Canada
    J Neuropsychiatry Clin Neurosci 10:220-3. 1998
  8. ncbi Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae
    A B Gold
    Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue Rm FG 05, Toronto, ON M4N 3M5, Canada
    Curr Drug Targets 12:243-55. 2011
  9. pmc Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease
    W Swardfager
    Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    Brain Behav Immun 25:1264-71. 2011

Collaborators

  • R H Swartz
  • P Yang
  • W Swardfager
  • K L Lanctot
  • A Adibfar
  • P I Oh
  • A Kiss
  • M Saleem
  • A B Gold
  • B R Shah
  • S E Black
  • M M Khan
  • A C Andreazza
  • M Daigle
  • P Shammi
  • S Marzolini
  • P R Albert

Detail Information

Publications9

  1. ncbi The management of behavioural disturbances in dementia: the role of serotonergic therapies
    N Herrmann
    Division of Geriatric Psychiatry, Sunnybrook Health Science Center, Department of Pharmacology, University of Toronto, 2075 Bayview Avenue, Room FG20, North York, Ontario M4N 3M5, Canada
    IDrugs 1:214-20. 1998
    ..The pharmacotherapy of behavioral disturbances is reviewed, focusing on serotonergic agents...
  2. ncbi Effectiveness of gabapentin for the treatment of behavioral disorders in dementia
    N Herrmann
    Division of Geriatric Psychiatry, University of Toronto, Ontario, Canada
    J Clin Psychopharmacol 20:90-3. 2000
    ..Gabapentin may have a role in treating a subgroup of dementia patients with severe behavioral disorders who have not responded to neuroleptics...
  3. doi Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes
    W Swardfager
    University of Toronto, Toronto, ON, Canada
    Diabet Med 33:529-36. 2016
    ..To quantify the impact of depressive symptoms on completion of exercise-based rehabilitation for Type 2 diabetes management...
  4. ncbi From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia
    N Herrmann
    University of Toronto, Ontario
    Can J Psychiatry 42:51S-64S. 1997
    ....
  5. pmc Poststroke neuropsychiatric symptoms: relationships with IL-17 and oxidative stress
    W Swardfager
    Neuropsychopharmacology Research Group, Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5 Department of Psychiatry, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5 Canadian Partnership for Stroke Recovery, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5 Division of Cognitive Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada M4N 3M5 L C Campbell Cognitive Neurology Research Unit, Sunnybrook Research Institute, Toronto, ON, Canada M4N 3M5
    Biomed Res Int 2014:245210. 2014
    ..In conclusion, poststroke depressive symptoms may be associated with cognitive vulnerability to IL-17 related pathways, involving an imbalance between proinflammatory and anti-inflammatory activity and increased oxidative stress. ..
  6. ncbi Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
    A Adibfar
    Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Suite FG 08, M4N 3M5, Toronto, Canada
    Curr Mol Med 16:137-64. 2016
    ..Further investigating the mechanisms underlying those markers and exploring novel pathways, such as oxidative stress, will extend the current state of knowledge and potentially lead to the identification of novel therapeutic targets...
  7. ncbi Risperidone for the treatment of behavioral disturbances in dementia: a case series
    N Herrmann
    Sunnybrook Health Science Centre, University of Toronto, Royal Ottawa Hospital, University of Ottawa, Canada
    J Neuropsychiatry Clin Neurosci 10:220-3. 1998
    ..Risperidone, in low doses, was well tolerated; 50% of patients experienced significant improvement, although 50% experienced some extrapyramidal symptoms...
  8. ncbi Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae
    A B Gold
    Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue Rm FG 05, Toronto, ON M4N 3M5, Canada
    Curr Drug Targets 12:243-55. 2011
    ....
  9. pmc Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease
    W Swardfager
    Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    Brain Behav Immun 25:1264-71. 2011
    ..To assess serum brain derived neurotrophic factor (BDNF) concentrations as a correlate of cardiopulmonary fitness and as a predictor of cognitive performance in subjects with coronary artery disease (CAD)...